Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stada Arzneimittel
Pharma
Stada charts strong first half of 2024 as owners weigh options
As Stada's owners continue to weigh their options, the German drugmaker gave a good indication Wednesday of exactly what it can bring to the table.
Fraiser Kansteiner
Aug 28, 2024 4:25pm
Stada in 'exploratory' phase of potential sale: CEO
Aug 15, 2023 2:14pm
Stada buys another clutch of consumer health brands from Sanofi
Jul 12, 2023 9:01am
With boost from Romania, Stada breaks ground on $50M plant
Nov 28, 2022 10:05am
Europe blesses Calliditas' kidney disease drug Kinpeygo
Jul 18, 2022 11:09am
Sandoz, Stada launch generic Revlimid in Europe
Feb 18, 2022 11:09am